Pricing standards for combined and modified new drugs in urgent need.

Published: 2005-04-19 06:57:00

Updated: 2005-04-19 06:57:00

To foster the R&D of a modified new drug that was suggested as one of the future drug industrial development issues, it is urgently required for the drug pricing account standards especially of the combined and modified new drugs according to a study reported by the chief researcher, Gill Young-s...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK